Trevi Therapeutics, Inc. TRVI Write Off Of Deferred Offering Costs
Write Off Of Deferred Offering Costs at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept trvi:WriteOffOfDeferredOfferingCosts.
The official record: Trevi Therapeutics, Inc.’s 10-K, filed March 17, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s write off of deferred offering costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s write off of deferred offering costs?
- Trevi Therapeutics, Inc. (TRVI) reported write off of deferred offering costs of $6.5K in Q4 2025.
- What does write off of deferred offering costs mean?
- This represents the non-cash expense recognized when previously capitalized costs associated with a planned or aborted financing transaction are written off. It indicates that the company has abandoned a specific capital-raising effort, requiring the immediate expensing of related legal, accounting, and filing fees. Monitoring this helps investors identify costs associated with failed financing attempts that do not provide future economic benefits.